Disease activity level, remission and response in established rheumatoid arthritis: Performance of various criteria sets in an observational cohort, treated with anti-TNF agents

被引:31
|
作者
Gulfe, Anders [1 ]
Aletaha, Daniel [2 ]
Saxne, Tore [1 ]
Geborek, Pierre [1 ]
机构
[1] Univ Lund Hosp, Dept Rheumatol, S-22185 Lund, Sweden
[2] Med Univ Vienna, Vienna, Austria
来源
BMC MUSCULOSKELETAL DISORDERS | 2009年 / 10卷
关键词
COLLEGE-OF-RHEUMATOLOGY; CLINICAL-PRACTICE; ACTIVITY INDEX; VALIDATION; PREDICTORS; REGISTER; THERAPY;
D O I
10.1186/1471-2474-10-41
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Most composite indices of disease activity and response criteria in RA have been validated and compared in clinical trials rather than routine care. We therefore wanted to compare the performance of the DAS28, SDAI and CDAI activity indices, their activity states, their response criteria, and also compare with the ACR response criteria in an observational clinical setting. Methods: Agreement between the criteria sets was investigated using kappa statistics in a non-randomized cohort of 1789 RA patients from southern Sweden, starting their first course of anti-TNF-treatment. Mean disease duration was 12 years. Completer analysis was used. Results: Agreement between high, moderate and low activity states was moderate or substantial, with. = 0.5 or better for all criteria. Agreement between SDAI and CDAI disease states was > 90% in these categories with kappa > 0.8. DAS28 original and modified cut point remission had good agreement (kappa = 0.91). Agreement between responses was substantial at the overall/ACR20 level (about 95%, kappa = 0.7 or better) for all criteria. By contrast, agreement was poor between moderate and high level responses. Conclusion: Disease activity states according to the various indices perform similarly and show substantial agreement at all levels except remission. Agreement between SDAI and CDAI states is excellent. Response criteria, applied at the individual patient level, are hard to interpret and show poor agreement, except at the lowest level of response. Thus, they should not be applied uncritically in clinical practice.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Disease activity level, remission and response in established rheumatoid arthritis: Performance of various criteria sets in an observational cohort, treated with anti-TNF agents
    Anders Gülfe
    Daniel Aletaha
    Tore Saxne
    Pierre Geborek
    BMC Musculoskeletal Disorders, 10
  • [2] New and established criteria for remission and disease activity in an observational RA cohort treated with etanercept.
    Geborek, Pierre
    Gulfe, Anders
    Aletaha, Daniel
    Kristensen, Lars Erik
    Saxne, Tore
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S203 - S204
  • [3] A comparison of response criteria in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-TNFα agents
    Lurati, A
    Pontikaki, I
    Teruzzi, B
    Desiati, F
    Gerloni, V
    Gattinara, M
    Cimaz, R
    Fantini, F
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S91 - S91
  • [4] PREDICTORS OF ACR/EULAR BOOLEAN AND SDAI REMISSION IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS TREATED WITH ANTI-TNF: AN ANALYSIS FROM THE PROSPECTIVE, OBSERVATIONAL REGISTRY, BIOTRAC
    Haraoui, B.
    Sheriff, M.
    Khraishi, M.
    Starr, M.
    Kelsall, J.
    Baker, M.
    Arendse, R.
    Dixit, S.
    Bensen, W.
    Baer, P.
    Faraawi, R.
    Rampakakis, E.
    Sampalis, J. S.
    Otawa, S.
    Lehman, A.
    Nantel, F.
    Shawi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 265 - 265
  • [5] Predictors of ACR/EULAR Boolean and SDAI Remission in Patients with Established Rheumatoid Arthritis Treated with Anti-TNF: An Analysis from the Prospective, Observational Registry, BioTRAC
    Haraoui, Boulos
    Sheriff, Maqbool
    Khraishi, Majed
    Starr, Michael
    Kelsall, John
    Baker, Milton
    Arendse, Regan
    Dixit, Sanjay
    Bensen, William
    Baer, Philip
    Faraawi, Rafat
    Rampakakis, Emmanouil
    Sampalis, John
    Lehman, Allen
    Nantel, Francois
    Shawi, May
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1443 - 1444
  • [6] Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis
    Park, M-C
    Jung, S-J
    Park, Y-B
    Lee, S-K
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 (03) : 173 - 178
  • [7] Anti-TNFα discontinuation in rheumatoid and psoriatic arthritis: Is it possible after disease remission?
    Chimenti, Maria Sole
    Graceffa, Dario
    Perricone, Roberto
    AUTOIMMUNITY REVIEWS, 2011, 10 (10) : 636 - 640
  • [8] Sustained Remission in Anti-TNF Treated Rheumatoid Arthritis Patients. Observational Data From Southern Sweden.
    Einarsson, Jon T.
    Geborek, Pierre
    Saxne, Tore
    Kapetanovic, Meliha C.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S164 - S165
  • [9] Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE)
    Ceccarelli, F.
    Massafra, U.
    Perricone, C.
    Idolazzi, L.
    Giacomelli, R.
    Tirri, R.
    Russo, R.
    Pistone, G.
    Ruscitti, P.
    Parisi, S.
    Sainaghi, P. P.
    Cacciapaglia, F.
    Zullo, A.
    Marino, V.
    Migliore, A.
    Valesini, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (01) : 24 - 32
  • [10] Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis
    Haberhauer, Guenther
    Strehblow, Christoph
    Fasching, Peter
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (9-10) : 220 - 224